ATP Colorimetric Assay Kit
中文名称:ATP含量比色法测试盒
Price:
Size:
100Assays(48 samples)
50Assays(24 samples)
- 样本类型: 组织
- 检测仪器及波长: 紫外-可见光分光光度计(636 nm)
- 研究领域: 氧化应激
说明书或网站上未涉及的样本类型请先跟技术支持沟通,可进行售前验证
根据需测样本数,试剂盒测样本孔数和单个样本测量孔数来计算所需生化试剂盒数量,请点击按钮 计算
生化试剂盒数量计算器x
需测样本数:
单个样本测量孔数:
试剂盒测样本孔数:
- 16
- 18
- 19
- 22
- 23
- 24
- 25
- 32
- 36
- 40
- 42
- 43
- 44
- 46
- 48
- 50
- 80
- 86
- 92
- 96
- 100
- 480
x
所需盒子量:
检测原理 |
肌酸激酶催化肌酸和 ATP 反应生成磷酸肌酸,通过比色法检测磷酸肌酸的含量,以此反应出ATP的含量。
|
灵敏度 | 0.01 mmol/L |
检测范围 | 0.01-1.5 mmol/L |
精密度 | 批间差:9.3% | 批内差:3.6% |
检测时间 | 70 min |
检测仪器及波长 | 紫外-可见光分光光度计(636 nm) |
保存条件 | 该产品可在 2~8°C/-20°C避光条件下保存6个月,具体试剂组分的保存条件请参考说明书。 |
有效期 | 6个月 |
-
Modulating gut dysbiosis and mitochondrial dysfunction in oxazolone-induced ulcerative colitis: the restorative effects of β-glucan and/or celastrol
IF: 4.412 -
Effects of pramipexole on beta-amyloid1–42 memory deficits and evaluation of oxidative stress and mitochondrial function markers in the hippocampus of Wistar rat
IF: 4.398Journal:NEUROTOXICOLOGY -
Glucose deprivation using 2-deoxyglucose and acarbose induce metabolic oxidative stress and apoptosis in female mice bearing breast cancer
IF: 4.079 -
Metabolic Phenotype Intricacies on Altered Glucose Metabolism of Breast Cancer Cells upon Glut-1 Inhibition and Mimic Hypoxia In Vitro
IF: 3.094Journal:APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY -
Honokiol Reduces Mitochondrial Dysfunction and Inhibits Apoptosis of Nerve Cells in Rats with Traumatic Brain Injury by Activating the Mitochondrial Unfolded Protein Response
IF: 2.866Journal:JOURNAL OF MOLECULAR NEUROSCIENCE -
San-Huang-Chai-Zhu Formula Ameliorates Liver Injury in Intrahepatic Cholestasis through Suppressing SIRT1/PGC-1α-Regulated Mitochondrial Oxidative Stress
IF: 2.65Journal:Evidence-based Complementary and Alternative Medicine -
Salvianolic acid A promotes mitochondrial biogenesis and function via regulating the AMPK/PGC‑1α signaling pathway in HUVECs
IF: 2.447Journal:Experimental and Therapeutic Medicine -
Simple neutralization test report: Do probiotics contribute to COVID-19 therapy?